Adalimumab biosimilars versus Azathioprine: indirect comparison of efficacy, safety and persistence in treatment

被引:0
|
作者
Saladino, M. [1 ,2 ]
Celsa, C. [2 ]
Amato, L. M. [3 ,4 ]
Di Giorgio, F. M. [3 ,4 ]
Muscarella, S. [3 ,4 ]
Melatti, P. [1 ,3 ]
Brinch, D. [1 ,3 ]
Cappello, M. [1 ,3 ]
机构
[1] Univ Palermo, Gastroenterol & Hepatol Sect, Promise, Palermo, Italy
[2] Univ Palermo, Dept Hlth Promot Mother & Child Care Internal Med, Palermo, Italy
[3] Univ Palermo, Gastroenterol & Hepatol Sect, Palermo, Italy
[4] Dept Hlth Promot Mother & Child Care Internal Med, Palermo, Italy
来源
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
P760
引用
收藏
页码:891 / 891
页数:1
相关论文
共 50 条
  • [41] Head-to-Head Comparison of Subcutaneous Abatacept Versus Adalimumab in the Treatment of Rheumatoid Arthritis: Key Efficacy and Safety Results from the AMPLE (Abatacept Versus Adalimumab Comparison in Biologic-Naive RA Subjects with Background Methotrexate) Trial
    Maldonado, Michael
    Weinblatt, Michael
    Schiff, Michael
    Fleischmann, Roy
    Valente, Robert
    Van der Heijde, Desiree
    Citera, Gustavo
    Zhao, Cathy
    JOURNAL OF RHEUMATOLOGY, 2013, 40 (06) : 1005 - 1006
  • [42] Comparison of Mizoribine with Azathioprine in Efficacy and Safety for ANCA-Associated Vasculitis
    Fukui, Sho
    Kawaai, Satoshi
    Kidoguchi, Genki
    Nakai, Takehiro
    Ozawa, Hiroki
    Koido, Ayako
    Ikeda, Yukihiko
    Suda, Masei
    Yanaoka, Haruyuki
    Shimizu, Hisanori
    Tamaki, Hiromichi
    Tsuda, Tokutaro
    Kishimoto, Mitsumasa
    Yamaguchi, Kenichi
    Okada, Masato
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [43] Comparison of two treatment strategies in IBD: Biosimilar adalimumab (CinnoRA®) in monotherapy and in combination with azathioprine
    AlborziAvanaki, F.
    Moghbel, N.
    Aletaha, N.
    Daryani, N. E.
    Farahvash, M. J.
    Miroliaii, A.
    Shayegan, N.
    Anjidani, N.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I370 - I371
  • [44] Comparison of two treatment strategies in IBD: Biosimilar adalimumab (CinnoRA®) in monotherapy and in combination with azathioprine
    AlborziAvanaki, F.
    Moghbel, N.
    Aletaha, N.
    Daryani, N. E.
    Farahvash, M. J.
    Miroliaii, A.
    Shayegan, N.
    Anjidani, N.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I370 - I371
  • [45] Efficacy and Safety of Commonly Used Insulin Analogues in the Treatment of Diabetic Ketoacidosis: A Bayesian Indirect Treatment Comparison
    Vidyasagar, Kota
    Chandrasekar, Boya
    Chhabra, Manik
    Bhansali, Anil
    Bansal, Dipika
    CLINICAL THERAPEUTICS, 2020, 42 (08) : E115 - E139
  • [46] Matching-Adjusted Indirect Comparison of the Long-Term Efficacy of Deucravacitinib Versus Adalimumab for Moderate to Severe Plaque Psoriasis
    April W. Armstrong
    Sang Hee Park
    Vardhaman Patel
    Malcolm Hogan
    Wei-Jhih Wang
    David Davidson
    Viktor Chirikov
    Dermatology and Therapy, 2023, 13 : 2589 - 2603
  • [47] Matching-Adjusted Indirect Comparison of the Long-Term Efficacy of Deucravacitinib Versus Adalimumab for Moderate to Severe Plaque Psoriasis
    Armstrong, April W.
    Park, Sang Hee
    Patel, Vardhaman
    Hogan, Malcolm
    Wang, Wei-Jhih
    Davidson, David
    Chirikov, Viktor
    DERMATOLOGY AND THERAPY, 2023, 13 (11) : 2589 - 2603
  • [48] An indirect treatment comparison of the efficacy of pembrolizumab versus competing regimens for the adjuvant treatment of stage III melanoma
    Lorenzi, Maria
    Arndorfer, Stella
    Aguiar-Ibanez, Raquel
    Scherrer, Emilie
    Liu, Frank Xiaoqing
    Krepler, Clemens
    JOURNAL OF DRUG ASSESSMENT, 2019, 8 (01) : 135 - 145
  • [49] Comment on: Treatment efficacy and safety of adalimumab versus tocilizumab in patients with active and severe Takayasu arteritis. Reply
    Wang, Jinghua
    Kong, Xiufang
    Jin, Xuejuan
    Jiang, Lindi
    RHEUMATOLOGY, 2024, 63 (09) : e276 - e277
  • [50] SECUKINUMAB FOR THE TREATMENT OF ANKYLOSING SPONDYLITIS: COMPARATIVE EFFECTIVENESS RESULTS VERSUS ADALIMUMAB USING A MATCHING-ADJUSTED INDIRECT COMPARISON
    Maksymowych, W.
    Strand, V
    Baeten, D.
    Nash, P.
    Thom, H.
    Hunger, M.
    Gandhi, K.
    Richards, H.
    Jugl, S.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (04) : 782 - 782